PTC Therapeutics (PTCT)

PTC Therapeutics (PTCT) Financial Statements


PTC Therapeutics Financial Overview

PTC Therapeutics's market cap is currently ―. The company's EPS TTM is $-7.685; its P/E ratio is -4.33; PTC Therapeutics is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-1.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 307.06M$ 196.58M$ 174.59M$ 220.38M$ 167.41M
Gross Profit$ 277.94M$ 196.58M$ 213.81M$ 220.38M$ 167.41M
EBIT-$ -166.59M$ -237.48M$ -107.66M$ -165.19M
EBITDA-$ -101.48M$ -183.18M$ -68.24M-
Net Income Common Stockholders$ -155.79M$ -113.98M$ -198.88M$ -138.96M$ -170.89M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 876.74M$ 294.81M$ 337.94M$ 286.30M$ 410.70M
Total Assets$ 1.90B$ 1.26B$ 1.34B$ 1.61B$ 1.71B
Total Debt$ 415.03M$ 704.35M$ 702.68M$ 701.17M$ 703.65M
Net Debt$ -461.71M$ 409.54M$ 364.74M$ 414.87M$ 292.95M
Total Liabilities$ 2.71B$ 1.93B$ 1.92B$ 2.07B$ 1.71B
Stockholders Equity$ -818.55M$ -670.82M$ -579.25M$ -457.56M$ -347.11M
Cash Flow-
Free Cash Flow-$ -45.23M$ 95.50M$ -75.56M$ -199.25M
Operating Cash Flow$ -100.29M$ -16.02M$ 114.78M$ -31.89M$ -172.25M
Investing Cash Flow$ -94.42M$ -28.10M$ -152.65M$ -26.57M$ 38.74M
Financing Cash Flow$ 620.49M$ 3.36M$ 18.46M$ 4.09M$ 302.92M
Currency in USD

PTC Therapeutics Earnings and Revenue History

PTC Therapeutics Debt to Assets

PTC Therapeutics Cash Flow

PTC Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis